3Mitra S,Gaur U,Ghosh PC,et al.Tumor targeted delivery of encapsulated dextran-doxorbicin conjugate using chitosan nanoparticles as carrier[J].J Control Release,2001,74(1-3):317.
5Wong NS,Anderson BO,Khoo KS,et al.Breast cancer in developing countries.Lancet,2009,374(9701):1567.
6Lubbea S,Alexiou C,Bercemann C.Clinical application of magnetic drug targeting.Surg Res,2001,95(2):200-206.
7Embleton MJ.Drug by monocional antibodiest.Br J Cancer,1987,55(3):227-231.
8Foged C,Nielsen HM,Frokjaer S.Liposomes for phospholipase A2 triggered siRNA release:preparation and in vitro test.Int J Pharm,2007,331(2):160-166.
9Vasir JK,Labhasetwar V.Targeted drug delivery in cancer therapy.Technol Cancer Res Treat,2005,4(4):363-374.
10Van Vlerken LE,Duan Z,Little SR,et al.Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model.Mol Pharm,2008,5(4):516-526.
